Aldeyra Non Recurring vs Research Development Analysis

ALDX Stock

USD 3.91 0.12 3.17%

Aldeyra financial indicator trend analysis is way more than just evaluating Aldeyra prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aldeyra is a good investment. Please check the relationship between Aldeyra Non Recurring and its Research Development accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aldeyra. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.

Non Recurring vs Research Development

Non Recurring vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aldeyra Non Recurring account and Research Development. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Aldeyra's Non Recurring and Research Development is -0.62. Overlapping area represents the amount of variation of Non Recurring that can explain the historical movement of Research Development in the same time period over historical financial statements of Aldeyra, assuming nothing else is changed. The correlation between historical values of Aldeyra's Non Recurring and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Recurring of Aldeyra are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Non Recurring i.e., Aldeyra's Non Recurring and Research Development go up and down completely randomly.

Correlation Coefficient

-0.62

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Non Recurring

Research Development

Most indicators from Aldeyra's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aldeyra current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aldeyra. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.Enterprise Value is likely to rise to about 81.8 M in 2024, whereas Selling General Administrative is likely to drop slightly above 8.1 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	1.7M	1.7M	2.1M	2.2M
Depreciation And Amortization	185.4K	2.3M	262.8K	249.6K

Interest Expense Depreciation And Amortization

Aldeyra fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Current Deferred Revenue	Long Term Debt	Net Receivables	Non Current Liabilities Total	Non Currrent Assets Other
Total Assets		0.85	0.68	0.71	0.99	0.75	-0.95	-0.84	0.36	0.93	0.29	1.0	0.85	0.87	0.73	0.71	0.75	1.0	0.25	0.89	-0.48	0.58	0.8	0.61	-0.04	0.19
Short Long Term Debt Total	0.85		0.73	0.78	0.82	0.81	-0.75	-0.8	0.46	0.76	0.28	0.85	0.78	0.79	0.59	0.75	0.81	0.85	0.29	0.81	-0.43	0.54	0.91	0.42	0.0	0.18
Other Current Liab	0.68	0.73		0.33	0.65	0.36	-0.49	-0.45	0.11	0.49	-0.31	0.67	0.41	0.46	0.81	0.6	0.36	0.68	-0.31	0.49	-0.36	0.38	0.52	0.47	0.1	-0.41
Total Current Liabilities	0.71	0.78	0.33		0.67	0.97	-0.76	-0.96	0.3	0.8	0.78	0.7	0.95	0.94	0.39	0.67	0.97	0.7	0.79	0.93	-0.42	0.61	0.92	0.08	-0.03	0.71
Total Stockholder Equity	0.99	0.82	0.65	0.67		0.72	-0.94	-0.8	0.4	0.92	0.26	0.99	0.82	0.84	0.72	0.61	0.72	0.99	0.22	0.86	-0.51	0.59	0.77	0.64	-0.1	0.17
Property Plant And Equipment Net	0.75	0.81	0.36	0.97	0.72		-0.81	-0.94	0.4	0.84	0.74	0.75	0.94	0.92	0.33	0.69	1.0	0.75	0.72	0.93	-0.48	0.65	0.94	0.27	-0.09	0.65
Net Debt	-0.95	-0.75	-0.49	-0.76	-0.94	-0.81		0.87	-0.27	-1.0	-0.47	-0.95	-0.91	-0.92	-0.59	-0.67	-0.81	-0.94	-0.44	-0.92	0.42	-0.54	-0.8	-0.58	0.0	-0.39
Retained Earnings	-0.84	-0.8	-0.45	-0.96	-0.8	-0.94	0.87		-0.26	-0.9	-0.69	-0.83	-0.99	-0.99	-0.55	-0.76	-0.94	-0.83	-0.67	-0.99	0.5	-0.65	-0.9	-0.2	0.07	-0.6
Accounts Payable	0.36	0.46	0.11	0.3	0.4	0.4	-0.27	-0.26		0.24	0.22	0.37	0.3	0.25	0.03	0.04	0.4	0.36	0.13	0.3	-0.44	0.48	0.46	0.37	-0.5	0.14
Cash	0.93	0.76	0.49	0.8	0.92	0.84	-1.0	-0.9	0.24		0.51	0.93	0.93	0.94	0.58	0.69	0.84	0.93	0.48	0.94	-0.42	0.55	0.83	0.54	0.01	0.43
Non Current Assets Total	0.29	0.28	-0.31	0.78	0.26	0.74	-0.47	-0.69	0.22	0.51		0.28	0.7	0.66	-0.11	0.33	0.74	0.28	0.97	0.63	-0.22	0.36	0.59	-0.2	-0.12	0.99
Cash And Short Term Investments	1.0	0.85	0.67	0.7	0.99	0.75	-0.95	-0.83	0.37	0.93	0.28		0.84	0.86	0.72	0.71	0.75	1.0	0.24	0.88	-0.48	0.57	0.8	0.62	-0.04	0.18
Common Stock Total Equity	0.85	0.78	0.41	0.95	0.82	0.94	-0.91	-0.99	0.3	0.93	0.7	0.84		1.0	0.52	0.7	0.94	0.85	0.68	1.0	-0.49	0.65	0.9	0.27	-0.08	0.62
Common Stock Shares Outstanding	0.87	0.79	0.46	0.94	0.84	0.92	-0.92	-0.99	0.25	0.94	0.66	0.86	1.0		0.58	0.72	0.92	0.86	0.64	1.0	-0.46	0.62	0.89	0.27	-0.03	0.58
Other Current Assets	0.73	0.59	0.81	0.39	0.72	0.33	-0.59	-0.55	0.03	0.58	-0.11	0.72	0.52	0.58		0.54	0.33	0.73	-0.14	0.58	-0.31	0.35	0.48	0.25	0.07	-0.15
Total Liab	0.71	0.75	0.6	0.67	0.61	0.69	-0.67	-0.76	0.04	0.69	0.33	0.71	0.7	0.72	0.54		0.69	0.71	0.3	0.72	-0.14	0.31	0.72	0.23	0.32	0.24
Property Plant And Equipment Gross	0.75	0.81	0.36	0.97	0.72	1.0	-0.81	-0.94	0.4	0.84	0.74	0.75	0.94	0.92	0.33	0.69		0.75	0.72	0.93	-0.48	0.65	0.94	0.27	-0.09	0.65
Total Current Assets	1.0	0.85	0.68	0.7	0.99	0.75	-0.94	-0.83	0.36	0.93	0.28	1.0	0.85	0.86	0.73	0.71	0.75		0.24	0.88	-0.48	0.57	0.8	0.61	-0.04	0.18
Short Term Debt	0.25	0.29	-0.31	0.79	0.22	0.72	-0.44	-0.67	0.13	0.48	0.97	0.24	0.68	0.64	-0.14	0.3	0.72	0.24		0.61	-0.13	0.31	0.56	-0.27	-0.02	0.97
Common Stock	0.89	0.81	0.49	0.93	0.86	0.93	-0.92	-0.99	0.3	0.94	0.63	0.88	1.0	1.0	0.58	0.72	0.93	0.88	0.61		-0.5	0.66	0.9	0.32	-0.07	0.54
Other Liab	-0.48	-0.43	-0.36	-0.42	-0.51	-0.48	0.42	0.5	-0.44	-0.42	-0.22	-0.48	-0.49	-0.46	-0.31	-0.14	-0.48	-0.48	-0.13	-0.5		-0.82	-0.43	-0.35	0.84	-0.1
Current Deferred Revenue	0.58	0.54	0.38	0.61	0.59	0.65	-0.54	-0.65	0.48	0.55	0.36	0.57	0.65	0.62	0.35	0.31	0.65	0.57	0.31	0.66	-0.82		0.52	0.29	-0.61	0.24
Long Term Debt	0.8	0.91	0.52	0.92	0.77	0.94	-0.8	-0.9	0.46	0.83	0.59	0.8	0.9	0.89	0.48	0.72	0.94	0.8	0.56	0.9	-0.43	0.52		0.32	-0.01	0.5
Net Receivables	0.61	0.42	0.47	0.08	0.64	0.27	-0.58	-0.2	0.37	0.54	-0.2	0.62	0.27	0.27	0.25	0.23	0.27	0.61	-0.27	0.32	-0.35	0.29	0.32		-0.11	-0.31
Non Current Liabilities Total	-0.04	0.0	0.1	-0.03	-0.1	-0.09	0.0	0.07	-0.5	0.01	-0.12	-0.04	-0.08	-0.03	0.07	0.32	-0.09	-0.04	-0.02	-0.07	0.84	-0.61	-0.01	-0.11		-0.05
Non Currrent Assets Other	0.19	0.18	-0.41	0.71	0.17	0.65	-0.39	-0.6	0.14	0.43	0.99	0.18	0.62	0.58	-0.15	0.24	0.65	0.18	0.97	0.54	-0.1	0.24	0.5	-0.31	-0.05

Click cells to compare fundamentals

Aldeyra Account Relationship Matchups

Aldeyra fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	75.5M	83.4M	233.1M	181.3M	148.3M	78.6M
Other Current Liab	11.9M	8.1M	10.5M	14.1M	(463.5K)	(440.4K)
Total Current Liabilities	12.9M	12.4M	11.8M	15.4M	22.3M	23.4M
Total Stockholder Equity	48.1M	59.5M	205.7M	151.0M	119.8M	62.4M
Property Plant And Equipment Net	349.5K	293.2K	384.4K	268.5K	516.6K	542.4K
Net Debt	(29.7M)	(62.5M)	(213.9M)	(128.3M)	(127.2M)	(120.8M)
Retained Earnings	(199.4M)	(236.9M)	(294.7M)	(356.7M)	(394.3M)	(374.5M)
Accounts Payable	808.3K	381.6K	1.0M	133.6K	1.3M	815.8K
Cash	44.4M	77.9M	229.8M	144.4M	142.8M	150.0M
Non Current Assets Total	349.5K	293.2K	384.4K	268.5K	5.0M	5.2M
Cash And Short Term Investments	73.4M	77.9M	229.8M	174.3M	142.8M	76.2M
Common Stock Total Equity	28.7K	38.7K	58.1K	58.6K	67.3K	70.7K
Common Stock Shares Outstanding	27.1M	34.0M	54.0M	58.4M	58.9M	61.9M
Liabilities And Stockholders Equity	75.5M	83.4M	233.1M	181.3M	148.3M	78.6M
Other Current Assets	1.8M	407.2K	3.0M	6.7M	523.5K	497.4K
Total Liab	27.4M	23.8M	27.4M	30.3M	28.5M	16.2M
Property Plant And Equipment Gross	349.5K	293.2K	384.4K	268.5K	516.6K	542.4K
Total Current Assets	75.2M	83.1M	232.8M	181.0M	143.3M	78.0M
Common Stock	28.7K	38.7K	58.1K	58.6K	59.2K	62.2K
Net Receivables	28M	25M	125M	3.2M	3.7M	3.5M
Non Current Liabilities Total	14.5M	11.4M	15.6M	14.9M	6.3M	8.8M
Non Currrent Assets Other	(54.9K)	(63.7K)	(96.1K)	249.3K	4.5M	4.7M
Other Stockholder Equity	247.4M	296.4M	500.4M	507.8M	514.0M	270.8M
Net Tangible Assets	48.1M	59.5M	205.7M	151.0M	173.7M	182.3M
Retained Earnings Total Equity	(199.4M)	(236.9M)	(294.7M)	(356.7M)	(321.0M)	(305.0M)
Property Plant Equipment	148.4K	59.9K	32.5K	19.3K	17.4K	16.5K
Capital Surpluse	247.4M	296.4M	500.4M	507.8M	583.9M	613.1M
Net Invested Capital	62.6M	74.6M	221.2M	166.8M	134.9M	123.8M
Net Working Capital	62.3M	70.6M	221.0M	165.7M	125.6M	121.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
GM	General Motors
CRM	Salesforce

When determining whether Aldeyra offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aldeyra's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aldeyra Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aldeyra Stock:

How To Invest In Aldeyra

Details

Is Aldeyra Stock a good investment?

Details

What is Aldeyra's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aldeyra. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more information on how to buy Aldeyra Stock please use our How to Invest in Aldeyra guide.

Note that the Aldeyra information on this page should be used as a complementary analysis to other Aldeyra's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Aldeyra Stock analysis

When running Aldeyra's price analysis, check to measure Aldeyra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aldeyra is operating at the current time. Most of Aldeyra's value examination focuses on studying past and present price action to predict the probability of Aldeyra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aldeyra's price. Additionally, you may evaluate how the addition of Aldeyra to your portfolios can decrease your overall portfolio volatility.

	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Is Aldeyra's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aldeyra. If investors know Aldeyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aldeyra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.51)

Return On Assets

(0.14)

Return On Equity

(0.24)

The market value of Aldeyra is measured differently than its book value, which is the value of Aldeyra that is recorded on the company's balance sheet. Investors also form their own opinion of Aldeyra's value that differs from its market value or its book value, called intrinsic value, which is Aldeyra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aldeyra's market value can be influenced by many factors that don't directly affect Aldeyra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aldeyra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aldeyra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aldeyra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aldeyra Non Recurring vs Research Development Analysis

Non Recurring vs Research Development

Non Recurring vs Research Development Correlation Analysis

Correlation Coefficient

Non Recurring

Research Development

Aldeyra fundamental ratios Correlations

Aldeyra Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aldeyra fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Aldeyra Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock Shares Outstanding	+ 1.0	Common Stock Total Equity
Common Stock	+ 1.0	Common Stock Total Equity

Cash	- 1.0	Net Debt
Common Stock	- 0.99	Retained Earnings
Common Stock Shares Outstanding	- 0.99	Retained Earnings
Common Stock Total Equity	- 0.99	Retained Earnings
Retained Earnings	- 0.96	Total Current Liabilities
Cash And Short Term Investments	- 0.95	Net Debt